Recent discussions on X about Scholar Rock Holding Corporation (SRRK) have been buzzing with activity following a significant insider purchase by a director, who reportedly acquired shares worth over $18 million. This move has sparked curiosity among investors, with many debating whether it signals strong confidence in the company’s future prospects amidst ongoing challenges. The high-profile transaction has kept the ticker trending on the platform.
Additionally, conversations have centered on the recent FDA delay for apitegromab, tied to manufacturing issues with a third-party partner, as noted in posts on X. Some users express concern over the potential impact on timelines, while others remain optimistic about the drug’s eventual approval given the lack of safety or efficacy concerns. This mix of reactions highlights the uncertainty and intrigue surrounding SRRK’s next steps.
Note: This discussion summary was generated from an AI condensation of post data.
Scholar Rock Holding Corporation Insider Trading Activity
Scholar Rock Holding Corporation insiders have traded $SRRK stock on the open market 35 times in the past 6 months. Of those trades, 6 have been purchases and 29 have been sales.
Here’s a breakdown of recent trading of $SRRK stock by insiders over the last 6 months:
- SRINIVAS AKKARAJU has made 6 purchases buying 500,439 shares for an estimated $18,807,352 and 0 sales.
- JEFFREY S. FLIER has made 0 purchases and 6 sales selling 48,663 shares for an estimated $1,650,994.
- MO QATANANI (CHIEF SCIENTIFIC OFFICER) has made 0 purchases and 4 sales selling 34,265 shares for an estimated $1,155,651.
- CARYN PARLAVECCHIO (CHRO) has made 0 purchases and 2 sales selling 8,364 shares for an estimated $265,840.
- JUNLIN HO (GENERAL COUNSEL) sold 7,442 shares for an estimated $238,154
- AKSHAY VAISHNAW (President of R&D) has made 0 purchases and 2 sales selling 6,750 shares for an estimated $200,612.
- RICHARD BRUDNICK has made 0 purchases and 2 sales selling 6,075 shares for an estimated $180,530.
- TRACEY SACCO (Chief Commercial Officer) has made 0 purchases and 2 sales selling 5,000 shares for an estimated $164,130.
- KRISTINA BUROW has made 0 purchases and 2 sales selling 5,400 shares for an estimated $160,510.
- JOSHUA REED has made 0 purchases and 2 sales selling 5,400 shares for an estimated $160,462.
- KATIE PENG has made 0 purchases and 4 sales selling 4,037 shares for an estimated $129,614.
- MICHAEL GILMAN has made 0 purchases and 2 sales selling 3,375 shares for an estimated $100,304.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Scholar Rock Holding Corporation Hedge Fund Activity
We have seen 125 institutional investors add shares of Scholar Rock Holding Corporation stock to their portfolio, and 105 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- OCTAGON CAPITAL ADVISORS LP removed 7,900,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $279,818,000
- PARADIGM BIOCAPITAL ADVISORS LP added 1,600,554 shares (+inf%) to their portfolio in Q2 2025, for an estimated $56,691,622
- POLAR CAPITAL HOLDINGS PLC removed 1,083,371 shares (-41.9%) from their portfolio in Q2 2025, for an estimated $38,373,000
- BALYASNY ASSET MANAGEMENT L.P. added 933,432 shares (+inf%) to their portfolio in Q2 2025, for an estimated $33,062,161
- PICTET ASSET MANAGEMENT HOLDING SA added 898,437 shares (+1009.2%) to their portfolio in Q2 2025, for an estimated $31,822,638
- NORGES BANK removed 815,541 shares (-41.0%) from their portfolio in Q2 2025, for an estimated $28,886,462
- ADAGE CAPITAL PARTNERS GP, L.L.C. removed 803,000 shares (-39.8%) from their portfolio in Q2 2025, for an estimated $28,442,260
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Scholar Rock Holding Corporation Analyst Ratings
Wall Street analysts have issued reports on $SRRK in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 09/24/2025
- HC Wainwright & Co. issued a "Buy" rating on 09/23/2025
- Jefferies issued a "Buy" rating on 08/21/2025
- BMO Capital issued a "Outperform" rating on 08/07/2025
- Cantor Fitzgerald issued a "Overweight" rating on 07/17/2025
To track analyst ratings and price targets for Scholar Rock Holding Corporation, check out Quiver Quantitative's $SRRK forecast page.
Scholar Rock Holding Corporation Price Targets
Multiple analysts have issued price targets for $SRRK recently. We have seen 5 analysts offer price targets for $SRRK in the last 6 months, with a median target of $45.0.
Here are some recent targets:
- Etzer Darout from Barclays set a target price of $44.0 on 09/24/2025
- Allison Bratzel from Piper Sandler set a target price of $51.0 on 09/24/2025
- Andres Y. Maldonado from HC Wainwright & Co. set a target price of $44.0 on 09/23/2025
- Amy Li from Jefferies set a target price of $50.0 on 08/21/2025
- Etzer Darout from BMO Capital set a target price of $45.0 on 08/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
